Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|121|10|1654-1661

ISSN: 0008-543x

Source: CANCER, Vol.121, Iss.10, 2015-05, pp. : 1654-1661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract